Utilizing TGF-β inhibitors for a Novel Approach to Hepatocellular Carcinoma
Joel Ravichandran Introduction: Hepatocellular carcinoma (HCC) is the second leading cause of cancer related death in the world due to its high-rate of metastasis and reoccurrence1,2. The most common cause is due to hepatitis B virus mediating cellular pathways and proteins in hepatocytes. Unfortunately, HCC is highly resistant to traditional…